Indoluidin D

Overview

Indoluidin D is a selective dihydroorotate dehydrogenase ( DHODH ) inhibitor with a human DHODH IC 50 of 210 nM. Indoluidin D selectively inhibits human DHODH activity, with induced effects rescuable by orotic acid. Indoluidin D promotes myeloid differentiation and inhibits cancer cell proliferation. Indoluidin D can be used for the research of acute promyelocytic leukemia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Dihydroorotate Dehydrogenase

Product Information

• Catalog No.: HY-182550
• CAS No.: 2763081-61-2
• Molecular Formula: C28H28N4O2
• Molecular Weight: 452.55
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source